|
DYAI
|
Dyadic International, Inc.
|
US
|
NASDAQ
|
|
EIGR
|
Eiger BioPharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
ELEV
|
Elevation Oncology, Inc.
|
US
|
NASDAQ
|
|
ENSC
|
Ensysce Biosciences, Inc.
|
US
|
NASDAQ
|
|
EQRX
|
EQRx, Inc.
|
US
|
NASDAQ
|
|
FWBI
|
First Wave BioPharma, Inc.
|
US
|
NASDAQ
|
|
GDRX
|
GoodRx Holdings, Inc.
|
US
|
NASDAQ
|
|
GMDA
|
Gamida Cell Ltd.
|
US
|
NASDAQ
|
|
HAPP
|
Happiness Biotech Group Limited
|
US
|
NASDAQ
|
|
HROW
|
Harrow Health, Inc.
|
US
|
NASDAQ
|
|
HUMA
|
Humacyte, Inc.
|
US
|
NASDAQ
|
|
IMAB
|
I-Mab
|
US
|
NASDAQ
|
|
INKT
|
MiNK Therapeutics, Inc.
|
US
|
NASDAQ
|
|
INZY
|
Inozyme Pharma, Inc.
|
US
|
NASDAQ
|
|
KTTA
|
Pasithea Therapeutics Corp.
|
US
|
NASDAQ
|
|
LEXX
|
Lexaria Bioscience Corp.
|
US
|
NASDAQ
|
|
LFMD
|
LifeMD, Inc.
|
US
|
NASDAQ
|
|
LIAN
|
LianBio
|
US
|
NASDAQ
|
|
LMDX
|
LumiraDx Limited
|
US
|
NASDAQ
|
|
LUMO
|
Lumos Pharma, Inc.
|
US
|
NASDAQ
|